NeuroSense Therapeutics NRSN Cash Flow Statement (2021-2025)

NASDAQ NRSN
$0.38 +0.03 (+7.39%)
At close: Aug 21, 2026 · 4:00 PM EDT
Cash Flow Statement Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025
Operating Activities
Net Income (Quarter) 5.18M7.16M-2.71M8.91M-15.39M19.68M-2.92M-3.65M-0.35M-3.19M-5.40M11.66M-14.67M18.62M
Share-based Compensation (Quarter) 0.04M1.44M
Gains from Investment Securities (Quarter) 0.22M6,304.00M2.69M
Financing Activities
Other financing activities (Quarter) 1.23M
Additional items
Beginning Cash Balance (Quarter) 0.70M0.70M11.06M11.06M3.54M2.64M3.38M